{"id":25992,"date":"2009-11-20T07:03:46","date_gmt":"2009-11-20T07:03:46","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/la-respuesta-a-la-eritropoyetina-alfa-recombinante-sin-el-complemento-del-factor-estimulante-de-colonias-de-granulocitos-se-asocia-a-una-mayor-supervivencia-en-pacientes-con-sindromes-mielodisplasic\/"},"modified":"2024-06-06T15:17:34","modified_gmt":"2024-06-06T15:17:34","slug":"la-respuesta-a-la-eritropoyetina-alfa-recombinante-sin-el-complemento-del-factor-estimulante-de-colonias-de-granulocitos-se-asocia-a-una-mayor-supervivencia-en-pacientes-con-sindromes-mielodisplasic","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/la-respuesta-a-la-eritropoyetina-alfa-recombinante-sin-el-complemento-del-factor-estimulante-de-colonias-de-granulocitos-se-asocia-a-una-mayor-supervivencia-en-pacientes-con-sindromes-mielodisplasic\/","title":{"rendered":"La respuesta a la eritropoyetina alfa recombinante, sin el complemento del factor estimulante de colonias de granulocitos, se asocia a una mayor supervivencia en pacientes con s\u00edndromes mielodispl\u00e1sicos dependientes de transfusiones."},"content":{"rendered":"\n<p>Musto P, Villani O, Martorelli MC, Pietrantuono G, Guariglia R, Mansueto G, D&#8217;Auria F, Grieco V, Bianchino G, Sparano A, Zonno A, Lerose R, Sanpaolo G, Falcone A. Leuk Res. 2010 ago;34(8):981-5. Epub 2009 Nov 20.<\/p>\n\n<p>Departamento de Onco-Hematolog\u00eda, Unidad de Hematolog\u00eda y Trasplante de C\u00e9lulas Madre, IRCCS, Centro di Riferimento Oncologico della Basilicata\u00bb, Via Padre Pio 1, 85028 Rionero in Vulture, Pz, Italia.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19931907\" target=\"_blank\" rel=\"noopener\"><span lang=\"EN-US\">Resumen<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Musto P, Villani O, Martorelli MC, Pietrantuono G, Guariglia R, Mansueto G, D&#8217;Auria F, Grieco V, Bianchino G, Sparano A, Zonno A, Lerose R, Sanpaolo G, Falcone A. Leuk Res. 2010 ago;34(8):981-5. Epub 2009 Nov 20. Departamento de Onco-Hematolog\u00eda, Unidad de Hematolog\u00eda y Trasplante de C\u00e9lulas Madre, IRCCS, Centro di Riferimento Oncologico della Basilicata\u00bb, Via <a href=\"https:\/\/patientbloodmanagement.org\/es\/resources\/la-respuesta-a-la-eritropoyetina-alfa-recombinante-sin-el-complemento-del-factor-estimulante-de-colonias-de-granulocitos-se-asocia-a-una-mayor-supervivencia-en-pacientes-con-sindromes-mielodisplasic\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[218],"tags":[],"class_list":["post-25992","resources","type-resources","status-publish","hentry","category-hematologia-oncologia"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/25992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=25992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=25992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=25992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}